- Services & Solutions
- Clients & Partners
Senior Clinical Director, Computational Science
David Sahner focuses on pursuing research opportunities at the nexus of computational science with systems biology and precision medicine, and within the domains of neuroinformatics, cognitive science, and artificial intelligence. He is a board certified internist with over 15 years of industry and non-profit-based experience in drug/biologic/device research and development across several therapeutic areas, along with nearly ten years of clinical practice following the completion of fellowship training at Brown University. Sahner has led, participated in teams, or managed individuals responsible for projects across a variety of domains, including infectious diseases, vaccines and vaccine adjuvants, immune-based therapy, oncology, neuroscience, and medical countermeasures, spanning all phases of R&D from research through post-licensure.
Prior to joining SRI, Sahner was principal at Aeneas Medical Consulting, where he provided biotechnology and pharmaceutical clients with services such as clinical strategy, protocol development, and product evaluation focused on virology, infectious diseases, and immunology. Earlier, he was vice president of clinical development at Nektar Therapeutics. In that role, he was responsible for clinical development, and clinical support for discovery and research programs.
Sahner’s broad experience also includes positions at Pfizer, where he was a clinical site head for virology, and Bristol-Myers Squibb, where he was director of infectious diseases clinical design and evaluation. He has also served as director of clinical development at Chiron Corporation. Prior to that, Sahner was an attending physician in the section of infectious diseases at Ellis Hospital in Schenectady, NY.
Sahner received his M.D. from McGill University and fellowship training in infectious diseases at Brown University. He is board certified in infectious diseases and internal medicine.